India IPO Watch: Shadowfax, KRM Ayurveda, and Digilogic Set to Hit Markets in January 2026

As the Indian stock market gears up for a busy week amid the January 2026 IPO calendar, three notable issues—Shadowfax Technologies, KRM Ayurveda, and Digilogic Systems—are scheduled to hit the primary market. These SME and mainboard offerings come on the heels of a subdued start to the year, with investors eyeing sectors like logistics, healthcare, and technology for potential gains. Shadowfax's mainboard IPO is particularly in the spotlight, backed by marquee investors, while the others target niche markets. Here's a detailed breakdown based on the latest Red Herring Prospectuses (RHPs) and market updates.

Shadowfax Technologies IPO: Logistics Giant's Mainboard Debut

Shadowfax Technologies, a Bengaluru-based third-party logistics (3PL) provider founded in 2015, is launching its much-anticipated IPO to fund expansion in a booming e-commerce ecosystem. The company operates a tech-enabled platform serving B2B clients across 14,758 pin codes as of September 2025, offering services like parcel logistics, hyperlocal deliveries, reverse logistics, and critical shipments. Backed by investors like Flipkart, Eight Roads, and IFC, Shadowfax has shown rapid growth but reported net losses in FY25 due to expansion costs.

Key Details:

• Issue Type: Book-built, mainboard (NSE/BSE)
• Opening Date: January 20, 2026
• Closing Date: January 22, 2026
• Anchor Bidding: January 19, 2026
• Price Band: ₹118 - ₹124 per share
• Lot Size: 120 shares
• Minimum Investment: ₹14,160 (at lower band) to ₹14,880 (at upper band) for retail investors
• Issue Size: ₹1,907.27 crore (Fresh issue: ₹1,000 crore; Offer for Sale: ₹907.27 crore by promoters and investors like Flipkart (₹400 crore), Eight Roads (₹197 crore), and others)
• Allotment Date: January 23, 2026 (tentative)
• Refund Initiation: January 26, 2026
• Listing Date: January 28, 2026 (tentative, NSE/BSE)
• GMP (Grey Market Premium): ₹14-15 (indicating 11-12% listing gain over upper band)
• Lead Managers: ICICI Securities Ltd.
• Registrar: Kfin Technologies Ltd.
• Objectives: Proceeds from the fresh issue will fund network infrastructure expansion (new first-mile, last-mile, and sort centers), capex for logistics facilities, lease payments, branding/marketing, potential acquisitions, and general corporate purposes.
• Financial Snapshot (FY25): Revenue growth but EPS ₹0.13, RoNW 0.97%, with negative cash flows and losses. Peers include Blue Dart (P/E 50.7) and Delhivery (P/E 195.07).
• Subscription Categories: 50% for QIBs, 15% for HNIs, 35% for retail.

Analysts view this as a growth play in India's logistics sector, projected to hit $380 billion by 2029, but caution on profitability amid competition.

KRM Ayurveda IPO: Ayurvedic Healthcare SME Offering

KRM Ayurveda, a Delhi-based company specializing in Ayurvedic products and wellness services, is entering the market with a focus on traditional medicine amid rising demand for natural health solutions. Incorporated in 2010, it offers formulations for immunity, digestion, and skincare, with a network of clinics and online presence.

Key Details:

• Issue Type: Book-built, SME (NSE Emerge)
• Opening Date: January 21, 2026 (most sources; some vary to Jan 19-21)
• Closing Date: January 23, 2026
• Price Band: ₹128 - ₹135 per share
• Lot Size: 1,000 shares
• Minimum Investment: ₹128,000 (at lower band) to ₹135,000 (at upper band) for retail investors
• Issue Size: ₹77.49 crore (Entirely fresh issue of ~0.57 crore equity shares)
• Allotment Date: January 24, 2026 (tentative)
• Listing Date: January 27-29, 2026 (tentative, NSE SME)
• GMP: ₹15 (+11.1% over upper band)
• Lead Manager: NEXGEN Financial Solutions Pvt. Ltd.
• Registrar: Skyline Financial Services Pvt. Ltd.
• Market Maker: Mansi Share & Stock Broking Pvt. Ltd.
• Objectives: Funds for working capital, new product development, clinic expansions, and general corporate needs (specifics from RHP).
• Financial Snapshot: Strong revenue from Ayurvedic sales, but details on EPS/RoNW not widely available; focus on post-COVID wellness boom.
• Subscription Categories: Standard SME allocation.

This IPO taps into India's ₹50,000 crore Ayurveda market, expected to grow at 15% CAGR, but faces risks from regulatory scrutiny on herbal claims.

Digilogic Systems IPO: Tech SME in Digital Solutions

Digilogic Systems, a Hyderabad-based firm providing digital communication and surveillance solutions since 2005, is aiming to raise funds for tech upgrades. It specializes in RF spectrum analyzers, data loggers, and telecom testing equipment, serving defense, telecom, and broadcasting sectors.

Key Details:

• Issue Type: Book-built, SME (NSE Emerge)
• Opening Date: January 20, 2026
• Closing Date: January 22, 2026
• Price Band: ₹98 - ₹104 per share (some sources note ₹98-103)
• Lot Size: 1,200 shares (or 1,199 in one variant, but 1,200 consistent)
• Minimum Investment: ₹117,600 (at lower band) to ₹124,800 (at upper band) for retail investors
• Issue Size: ₹81.01 crore (Fresh issue: 0.67 crore shares ~₹69.68 crore; OFS: 0.11 crore shares ~₹11.33 crore)
• Allotment Date: January 23, 2026
• Refund Initiation: January 26, 2026
• Listing Date: January 27-28, 2026 (tentative, NSE SME)
• GMP: Not widely reported; market sentiment neutral.
• Lead Manager: Indorient Financial Services Ltd.
• Registrar: Kfin Technologies Ltd.
• Objectives: Proceeds for R&D in digital tech, facility upgrades, working capital, and corporate purposes.
• Financial Snapshot: Focus on defense tech growth; EPS and RoNW details limited, but positive amid India's digital push.
• Subscription Categories: Standard SME.

With India's defense budget rising, Digilogic eyes opportunities in surveillance tech, though competition from global players poses risks.

Market Outlook and Investor Tips

Next week's IPOs (Jan 19-25) also include Bharat Coking Coal's mainboard listing on Jan 22, potentially drawing more liquidity. Total issues could raise over ₹2,000 crore, but GMPs suggest moderate listing pops amid volatile markets. Experts advise retail investors to review RHPs for risks like losses (Shadowfax) and sector dependencies. Subscription via ASBA or UPI is recommended; consult SEBI-registered advisors.

Stay tuned for subscription updates as these open—early trends often signal success.